Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With Clopidogrel
- 16 September 2008
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 52 (13), 1052-1059
- https://doi.org/10.1016/j.jacc.2008.05.054
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Elevated Plasma Fibrinogen Level Predicts Suboptimal Response to Therapy With Both Single- and Double-Bolus Eptifibatide During Percutaneous Coronary InterventionJournal of the American College of Cardiology, 2007
- Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent ThrombosisJournal of the American College of Cardiology, 2007
- Current Options in Platelet Function TestingThe American Journal of Cardiology, 2006
- Platelet Inhibition by Insulin Is Absent in Type 2 Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrelMethods and Findings in Experimental and Clinical Pharmacology, 2006
- Resistance to clopidogrel: A review of the evidenceJournal of the American College of Cardiology, 2005
- Variability in platelet responsiveness to clopidogrel among 544 individualsJournal of the American College of Cardiology, 2005
- A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C‐reactive protein following myocardial infarction: the CADET trialJournal of Thrombosis and Haemostasis, 2004
- Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and ProphylaxisSeminars in Thrombosis and Hemostasis, 1997
- Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels. In vivo study in the rabbit model.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991